On Wednesday, September 27, Vinay K. Prasad, MD, MPH, hematologist-oncologist and Assistant Professor of Medicine at the Oregon Health and Sciences University, will present the keynote address. Dr. Prasad will dissect the current challenges and offer visions for a future in which all patients have access to high-value cancer care.
Dr. Prasad holds appointments in the Division of Public Health and Preventive Medicine, and as a Senior Scholar in the Center for Health Care Ethics. He is nationally known for his research on oncology drugs, health policy, evidence-based medicine, bias, public health, preventive medicine and medical reversal. Clinically, Dr. Prasad specializes in the care of lymphoma patients, and attends on the leukemia/ lymphoma services.
Dr. Prasad's work has demonstrated that many medical practices, promoted and advocated for decades, are ultimately shown not to work. These reversals typically occur when we adopt new therapies based on incomplete or inadequate studies. Dr. Prasad has also demonstrated that the high cost of cancer drugs is not explained by rational factors, that media coverage of medical articles preferentially covers lower levels of evidence, that industry sponsored randomized trials have substantial bias and that many current medical practices have no convincing proof of efficacy (e.g., inferior vena cava (IVC) filters). Dr. Prasad and Adam Cifu, MD, of the University of Chicago, are authors of Ending Medical Reversal: Improving Outcomes, Saving Lives (Johns Hopkins University Press, 2015).
Dr. Prasad is a graduate of the University of Chicago Pritzker School of Medicine, where he was awarded the Chairman's Award in Internal Medicine. He is also a graduate of Johns Hopkins Bloomberg School of Public Health and completed his undergraduate degree at Michigan State University, where he was commencement speaker for the College of Arts and Letters. Dr Prasad trained in general internal medicine at Northwestern University Feinberg School of Medicine in Chicago, where he received the Gerald Grumet award for best resident teacher, and completed his fellowship in Hematology and Oncology in the joint program between the National Cancer Institute and the National Heart, Lung and Blood Institute, both at the National Institutes of Health (NIH), where he served as Chief Fellow. While at the NIH, Dr. Prasad was also a Cancer Prevention Fellow.
Visit the Online Conference Planner for the full schedule and details on the ASTRO Annual Meeting, and register now.